This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Hans Ehrsson: Innovator in Cancer Chemotherapy
Introduction
Hans Ehrsson is a notable inventor based in Sweden, recognized for his contributions to the field of cancer treatment. His work primarily focuses on developing new therapeutic drugs that can effectively combat carcinogenic diseases.
Latest Patents
Hans Ehrsson holds a patent titled "Melphalan Derivatives And Their Use As Cancer Chemotherapeutic Drugs." This invention refers to new alkylating di- and tripeptides based on the melphalan unit, combined with one or two additional amino acids or amino acid derivatives. These compounds are designed for use in the treatment of various cancerous conditions. Furthermore, the invention includes a pharmaceutical composition comprising the alkylating peptides developed by Ehrsson.
Career Highlights
Ehrsson is currently associated with Oncopeptides AB, a company dedicated to advancing cancer therapies. His innovative approach to drug development has positioned him as a key figure in the pharmaceutical industry, particularly in the realm of oncology.
Collaborations
Some of his notable coworkers include Joakim Gullbo and Rolf Lewensohn, who have collaborated with him on various projects aimed at enhancing cancer treatment options.
Conclusion
Hans Ehrsson's work in developing melphalan derivatives showcases his commitment to improving cancer therapies. His contributions are significant in the ongoing fight against cancer, and his innovative spirit continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile